First ‘postpartum’ pill
Brooke Steinberg
A first-of-its-kind pill for postpartum depression could be available to women in the US by August.
The drug, called Zuranolone, is now being reviewed by the Food and Drug Administration and could be approved by Aug. 6, said drugmakers Sage Therapeutics and Biogen.
The fast-acting antidepressant would be taken once a day for two weeks.
NEWS
en-us
2023-02-08T08:00:00.0000000Z
2023-02-08T08:00:00.0000000Z
https://nypost.pressreader.com/article/281526525213281
New York Post